Daniel Kaul, MD
About the NEJM Journal Watch Infectious Diseases Board
Daniel Kaul, MD, is Associate Professor of Medicine at the University of Michigan Medical School in Ann Arbor. He directs the Transplant Infectious Disease Service and serves as Infectious Disease Fellowship Program Director. His research interests include infectious complications of solid-organ and stem-cell transplantation. He is past chair of the United Network for Organ Sharing’s Disease Transmission Advisory Committee and serves on the education committee of the American Society of Transplantation and the program directors committee of the Infectious Disease Society of America. He has written for NEJM Journal Watch Infectious Diseases since 2017.
AAA Insurance Co.; State Farm Insurance Co.; Auto Owners Insurance Co.; Farm Bureau Insurance Co.
Chimerix; Gilead Sciences
Summaries by Daniel Kaul
- July 26, 2017
- Daniel Kaul, MD
Vigilance, and perhaps antimicrobial prophylaxis, against invasive meningococcal disease is required in eculizumab-treated patients despite meningococcal vaccination.